Polymorphisms in Adipokines in Mexican Children with Obesity

Table 2

Clinical and anthropometrical measurements according to obesity status.

	Nonobesity	Obesity	P
n	569	204
Age	9.3 (6.1–12.9)	11.3 (9.2–13.4)	<0.001
Male n, (%)	275 (48.3)	120 (58.8)	0.032
Body Fat (%)	23.9 ± 10.2	38.27 ± 8.7	<0.001
BMI	17.3 (15.7–19.7)	24.98 (22.5–21.6)	<0.001
Glucose	96 (90–103)	98 (92–105)	0.0199
HbA1c	5.4 (5.1–5.6)	5.44 (5.2–5.7)	0.2182
Creatinine	0.91 (0.77–1.07)	0.98 (0.83–1.14)	0.0018
TAG	87.5 (66.5–113)	120 (90–167)	<0.001
CHOL	162 (142–180)	170 (152–191)	0.0023
HDL	61.34 ± 12.34	56.77 ± 12.05	<0.001

Data are presented as mean ± SD for continuous variables with normal distribution, median (interquartile range) for continuous variables with nonnormal distribution. BMI: body mass index (kg/m²), HbA1c: glycated hemoglobin, TAG: triglycerides, CHOL: cholesterol, and HDL: high density lipoprotein cholesterol.